Nabumetone Tablets had U.S. sales of approximately $68 million for the 12 months ending March 31, 2010, according to IMS Health. Currently, Mylan has 134 ANDAs pending FDA approval representing $93.8 ...
PARSIPPANY, N.J., June 17, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States ...
Hypertension and knee osteoarthritis (OA) are frequent comorbidities. Nonsteroidal anti-inflammatory drugs (NSAIDs) are often used to relieve pain in such patients. In the last decade selective NSAIDs ...